Skip to content

Newsroom

Media Call Q2 2024

The Media Call for journalists on Q2 2024 financial results takes place on July 30, 2024

Order our news

Would you like to be included on our distribution list for our news? We would be happy to provide you with our latest press releases and short news by e-mail. This service is free of charge and may be cancelled at any time.

You can cancel this free service at any time by sending an e-mail to ir(at)freseniusmedicalcare.com, or by calling +49 (0) 6172 - 609 2525.

The information you provide will only be used to answer your query. For more information on how we process your Personal Data please read our privacy policy.

newsletter registration
captcha
| Short News
Fresenius Medical Care celebrates three employees achievements on International Women’s Day
| Press release
Fresenius Medical Care Achieves Next Milestone in Portfolio Optimization Program, Announcing Sale of Dialysis Clinics in Brazil, Colombia, Chile, Ecuador
| Press release
Fresenius Medical Care published form 20-F for the fiscal year 2023
| Press release
Fresenius Medical Care delivers on commitments in a year of fundamental transformation
| Press release
Fresenius Medical Care Brings Industry-Leading Dialysis Therapy to Kidney Disease Patients in the U.S., demonstrating Global Leadership in Medical Device and Membrane Engineering Technologies
| Press release
Fresenius Medical Care AG nominates Six Employee Representatives to the Supervisory Board
| Press release
Fresenius Medical Care Executes on Its Strategic Portfolio Optimization Program and Announces Key Transactions
| Press release
Fresenius Medical Care again included in Dow Jones Sustainability Index
| Press release
Fresenius Medical Care completes change of legal form into a German stock corporation
| Press release
Fresenius Medical Care enters into favorable settlement agreement with U. S. government with positive earnings impact of approx. EUR 175 million – 2023 earnings outlook raised
Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, resolved a legal dispute with the U.S. government, for accounts receivable in legal dispute, and entered into a final and legally binding settlement agreement today, whereby the company will receive a payment from the U.S. government.
| Press release
Fresenius Medical Care continues to execute on turnaround plan and raises 2023 earnings outlook due to strong operational performance in first nine months and solid business outlook for the fourth quarter
| Press release
Fresenius Medical Care appoints Craig Cordola as new Management Board member for Care Delivery
1 2 3 ... 26
Related content

Contacts

Do you have any questions? Contact us!

About us

Fresenius Medical Care is the world’s leading provider of dialysis products and services. Find out more about the company’s key facts and innovations.